Abiopharma

🔍 Ronaghi Mostafa (Director)

Company: Summit Therapeutics Inc. (SMMT)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 35,000 shares of Stock Option (right to buy) at $17.52 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 35,000.00 | transaction_form_type: 4 | Footnotes: F2, F1

Footnotes:

• F1: The option was granted on January 2, 2026. The shares underlying the option shall vest in four quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the reporting person remaining as a non-salaried director on each such vesting date.
• F2: Not applicable.